{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:08:26Z","timestamp":1790615306890,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.revmed.2016.02.014","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T20:29:39Z","timestamp":1464467379000},"page":"544-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Agranulocytoses aux antithyro\u00efdiens de synth\u00e8se\u00a0: revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"37","author":[{"given":"E.","family":"Andr\u00e8s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Weitten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mourot-Cottet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-A.","family":"Zulfiqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Serraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tebacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2016.02.014_bib0220","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1517\/14740338.7.4.481","article-title":"Recognition and managment of drug-induced blood-cytopenias: the example of drug-induced acute neutropenia and agranulocytosis","volume":"7","author":"Andr\u00e8s","year":"2008","journal-title":"Expert Opin Drug Safe"},{"key":"10.1016\/j.revmed.2016.02.014_bib0225","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2016.02.014_bib0230","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2016.02.014_bib0235","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","article-title":"Clinical practice. Graves\u2019 disease","volume":"358","author":"Brent","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2016.02.014_bib0240","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2265.2004.02135.x","article-title":"Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK","volume":"61","author":"Pearce","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.revmed.2016.02.014_bib0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.revmed.2005.06.008","article-title":"Groupe d\u2019\u00e9tude des agranulocytoses m\u00e9dicamenteuses des h\u00f4pitaux universitaires de Strasbourg. Agranulocytoses m\u00e9dicamenteuses idiosyncrasiques","volume":"27","author":"Andr\u00e8s","year":"2006","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2016.02.014_bib0250","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.297.6643.262","article-title":"IAAAS: International Agranulocytosis and Aplastic Anaemia Study. Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs","volume":"297","author":"Retsagi","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2016.02.014_bib0255","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4269\/ajtmh.1999.60.573","article-title":"Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group","volume":"60","author":"Shapiro","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.revmed.2016.02.014_bib0260","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1096-8652(199803)57:3<206::AID-AJH4>3.0.CO;2-Z","article-title":"Drug-associated agranulocytosis: 20\u00a0years of reporting in the Netherlands [1974\u20131994]","volume":"57","author":"Van der Klauw","year":"1998","journal-title":"Am J Hematol."},{"key":"10.1016\/j.revmed.2016.02.014_bib0265","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03344959","article-title":"Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature","volume":"17","author":"Meyer-Gessner","year":"1994","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.revmed.2016.02.014_bib0270","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1507\/endocrj.K05-068","article-title":"The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves\u2019 disease","volume":"54","author":"Tsuboi","year":"2007","journal-title":"Endocr J"},{"key":"10.1016\/j.revmed.2016.02.014_bib0275","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archinte.159.4.369","article-title":"A population-based case-cohort study of drug-associated agranulocytosis","volume":"159","author":"Van der Klauw","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2016.02.014_bib0280","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/thy.2005.15.292","article-title":"Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy?","volume":"15","author":"Tajiri","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.revmed.2016.02.014_bib0285","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/009127006200200603","article-title":"The relative toxicity of antithyroid drugs","volume":"2","author":"Trotter","year":"1962","journal-title":"J New Drugs"},{"issue":"Suppl. 4","key":"10.1016\/j.revmed.2016.02.014_bib0290","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1016\/j.revmed.2009.10.067","article-title":"R\u00e9seau National des Centres de Pharmacovigilance. Agranulocytose aux antithyro\u00efdiens de synth\u00e8se\u00a0: donn\u00e9es \u00e9pid\u00e9miologiques et cliniques. \u00c9tude de 203\u00a0cas issus de la base nationale de pharmacovigilance","volume":"30","author":"Weitten","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2016.02.014_bib0295","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-98-1-26","article-title":"Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose","volume":"98","author":"Cooper","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2016.02.014_bib0300","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0268-960X(90)90002-A","article-title":"Drug-induced agranulocytosis. Peripheral destruction of polymorphonuclear leukocytes and their marrow precursors","volume":"4","author":"Pisciotta","year":"1990","journal-title":"Blood Rev"},{"key":"10.1016\/j.revmed.2016.02.014_bib0305","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.1983.00350040049004","article-title":"Captopril-associated neutropenia","volume":"143","author":"Cooper","year":"1983","journal-title":"Who is at risk?. Arch Intern Med"},{"key":"10.1016\/j.revmed.2016.02.014_bib0310","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.0954-6820.1979.tb06084.x","article-title":"Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee","volume":"205","author":"B\u00f6ttiger","year":"1999","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.revmed.2016.02.014_bib0315","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1210\/jcem-58-5-868","article-title":"In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves\u2019 disease: a possible cause of antithyroid drug-induced agranulocytosis","volume":"58","author":"Wall","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2016.02.014_bib0320","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/archinte.144.8.1687","article-title":"Granulocytotoxic antibodies in a patient with PTU- induced agranulocytosis","volume":"144","author":"Guffy","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2016.02.014_bib0325","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(78)90915-7","article-title":"Drug-induced immunological neutropenia","volume":"1","author":"Weitzman","year":"1978","journal-title":"Lancet."},{"key":"10.1016\/j.revmed.2016.02.014_bib0330","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2141.1986.tb04130.x","article-title":"Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells","volume":"64","author":"Fibbe","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2016.02.014_bib0335","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/0006-2952(79)90692-0","article-title":"Accumulation of 2-[14C]propylthiouracil in human polymorphonuclear leukocytes","volume":"28","author":"Lam","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.revmed.2016.02.014_bib0340","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/thy.2000.10.595","article-title":"Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves\u2019 disease","volume":"10","author":"Sera","year":"2000","journal-title":"Thyroid"},{"key":"10.1016\/j.revmed.2016.02.014_bib0345","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1365-2249.2002.01720.x","article-title":"Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies [ANCA]: possible involvement of complement in granulocyte cytotoxicity","volume":"127","author":"Akamizu","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.revmed.2016.02.014_bib0350","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2265.1989.tb01424.x","article-title":"Methimazole-induced agranulocytosis in Japanese patients with Graves\u2019 disease","volume":"30","author":"Tamai","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl","key":"10.1016\/j.revmed.2016.02.014_bib0355","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0609.1996.tb01638.x","article-title":"Drug-related blood dyscrasias","volume":"60","author":"Young","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.revmed.2016.02.014_bib0360","doi-asserted-by":"crossref","first-page":"490","DOI":"10.7326\/0003-4819-124-5-199603010-00005","article-title":"Association between the DRB1*08032\u00a0histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease","volume":"124","author":"Tamai","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2016.02.014_bib0365","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5694\/j.1326-5377.1983.tb142086.x","article-title":"Recurrent agranulocytosis induced by two different antithyroid agents","volume":"2","author":"Chen","year":"1983","journal-title":"Med J Aust"},{"key":"10.1016\/j.revmed.2016.02.014_bib0370","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1742-1241.1988.tb08632.x","article-title":"Recurrent agranulocytosis following carbimazole and propylthiouracil therapy","volume":"42","author":"Ostlere","year":"1988","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.revmed.2016.02.014_bib0375","first-page":"329","article-title":"Drug-induced agranulocytosis: role of the myelogram and biological tests","volume":"59","author":"Jobert","year":"2001","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.revmed.2016.02.014_bib0380","first-page":"257","article-title":"Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting","volume":"33","author":"B\u00e9nichou","year":"1991","journal-title":"Nouv Rev Fr Hematol"},{"key":"10.1016\/j.revmed.2016.02.014_bib0385","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002\u00a0guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2016.02.014_bib0390","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0248-8663(96)80745-4","article-title":"Agranulocytoses aigu\u00ebs m\u00e9dicamenteuses. \u00c9tude clinique \u00e0 propos de 30\u00a0patients et \u00e9volution des \u00e9tiologies sur 2\u00a0d\u00e9cennies","volume":"16","author":"Paitel","year":"1995","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2016.02.014_bib0395","first-page":"2229","article-title":"Les agranulocytoses m\u00e9dicamenteuses. \u00c9tude clinique, biologique et \u00e9volutive. \u00c0 propos de 61\u00a0observations","volume":"62","author":"Simon","year":"1986","journal-title":"Sem Hop Paris"},{"key":"10.1016\/j.revmed.2016.02.014_bib0400","first-page":"508","article-title":"Agranulocytoses aigu\u00ebs m\u00e9dicamenteuses\u00a0: exp\u00e9rience du Centre R\u00e9gional de Pharmacovigilance de Lyon sur 7ans","volume":"51","author":"Vial","year":"1996","journal-title":"Th\u00e9rapie"},{"key":"10.1016\/j.revmed.2016.02.014_bib0405","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2257.2002.00437.x","article-title":"Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital [1985\u20132000] and review of the literature","volume":"24","author":"Andr\u00e8s","year":"2002","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.revmed.2016.02.014_bib0410","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/qjmed\/92.8.455","article-title":"Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections","volume":"92","author":"Sheng","year":"1999","journal-title":"QJM"},{"key":"10.1016\/j.revmed.2016.02.014_bib0415","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/thy.1999.9.29","article-title":"Granulocyte colony-stimulating factor [G-CSF] does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study","volume":"9","author":"Fukata","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.revmed.2016.02.014_bib0420","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/qjmed\/94.8.423","article-title":"The use of haematopoietic growth factors in antithyroid-related drug-induced agranulocytosis: a report of 20\u00a0patients","volume":"94","author":"Andr\u00e8s","year":"2001","journal-title":"Q J Med"},{"key":"10.1016\/j.revmed.2016.02.014_bib0425","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1507\/endocrj.49.29","article-title":"Retrospective analysis of 18\u00a0cases of antithyroid drug [ATD]-induced agranulocytosis","volume":"49","author":"Dai","year":"2002","journal-title":"Endocr J"},{"key":"10.1016\/j.revmed.2016.02.014_bib0215","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.1990.00390150107020","article-title":"Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring","volume":"150","author":"Tajiri","year":"1990","journal-title":"Arch Intern Med"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316000825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316000825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:36:21Z","timestamp":1759336581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866316000825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0248866316000825"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2016.02.014","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agranulocytoses aux antithyro\u00efdiens de synth\u00e8se\u00a0: revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2016.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}